肺癌
癌症
抗性(生态学)
碱性抑制剂
后天抵抗
医学
癌症研究
克里唑蒂尼
生物
内科学
生态学
恶性胸腔积液
作者
Gonzalo Recondo,Laura Mezquita,Francesco Facchinetti,David Planchard,Anas Gazzah,Ludovic Bigot,Ahsan Z. Rizvi,Rosa L. Frias,Jean Paul Thiery,Jean‐Yves Scoazec,Tony Sourisseau,Karen Howarth,Olivier Déas,Dariia Samofalova,Justine Galissant,Pauline Tesson,Floriane Brayé,Charles Naltet,Pernelle Lavaud,Linda Mahjoubi
标识
DOI:10.1158/1078-0432.ccr-19-1104
摘要
This study shows that mechanisms of resistance to lorlatinib are diverse and complex, requiring new therapeutic strategies to tailor treatment upon disease progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI